バンコマイシンの世界市場レポート 2025年

バンコマイシン市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.1％で14億米ドルに成長します。予測期間の成長は、新種の病原体の出現の増加、迅速かつオンサイトの検査ソリューションに対する需要の増加、早期検出システムに対する重点の高まり、バンコマイシンに対する需要の高まり、研究開発活動の活発化などに起因しています。予測期間における主な動向としては、診断機器の小型化・携帯化、複数の病原体を同時に検出できるマルチプレックスアッセイの採用、デジタルヘルスソリューションの統合、感染症診断における次世代シーケンシング（NGS）技術の採用、バイオセンサー技術の進歩、診断プラットフォームへのAI・機械学習アルゴリズムの統合などが挙げられます。

バンコマイシン市場は、細菌、ウイルス、真菌、寄生虫などの病原性微生物によって引き起こされる感染症の流行が増加しているため、成長が見込まれています。この増加の要因には、抗菌剤耐性、気候変動、人口増加などがあります。バンコマイシンは、重症グラム陽性菌感染症、特に耐性株の治療において、臨床ガイドラインと抗菌薬スチュワードシップに従い、患者の転帰を最適化するために重要な役割を果たしています。例えば、UNAIDSの報告によると、世界のHIV/AIDS人口は2023年に3,900万人を超え、2020年から3.17％の増加を示しています。また、米国では結核患者が2021年から2022年にかけて5.9％増加した（米国疾病対策予防センター）。

バンコマイシン市場の主なプレイヤーは、市場での地位を維持するために、抗感染症薬や降圧薬などの革新的な製品を積極的に開発しています。抗感染症薬は様々な微生物による感染症を対象とし、降圧剤は低血圧患者の血圧を上げるために使用されます。例えば、バクスター・インターナショナルは2024年4月に米国で5つの注射剤を発売し、麻酔、疼痛管理、特殊療法のニーズに対応し、患者の転帰改善への取り組みを示しました。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バンコマイシンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバンコマイシン市場：成長率分析
• 世界のバンコマイシン市場の実績：規模と成長, 2019-2024
• 世界のバンコマイシン市場の予測：規模と成長, 2024-2029, 2034F
• 世界バンコマイシン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバンコマイシン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射液
• 注射用粉末
• 世界のバンコマイシン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内
• オーラル
• 世界のバンコマイシン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 敗血症
• 肺感染症
• 皮膚軟部組織感染症
• 大腸炎と腸の炎症
• 感染を防ぐために
• 世界のバンコマイシン市場注射液の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレミックス注射液
• すぐに使える注射液
• 濃縮注射液
• 世界のバンコマイシン市場、注射用粉末の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バンコマイシン静脈内投与用粉末
• バンコマイシン再構成用パウダー

第7章 地域別・国別分析

• 世界のバンコマイシン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバンコマイシン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バンコマイシン市場：競合情勢
• バンコマイシン市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quest Diagnostics Incorporated
• Hologic Inc.
• bioMerieux SA
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Ortho Clinical Diagnostics Pvt. Ltd.
• DiaSorin SpA
• Myriad Genetics Inc.
• Seegene Inc.
• ANI Pharmaceuticals Inc.
• Alvogen Inc.
• Biodesix Inc.
• Helix OpCo LLC
• Inovio Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バンコマイシン市場2029：新たな機会を提供する国
• バンコマイシン市場2029：新たな機会を提供するセグメント
• バンコマイシン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vancomycin is a powerful antibiotic used against bacterial infections, particularly Gram-positive strains resistant to other antibiotics. It operates by impeding bacterial cell wall synthesis, halting bacterial growth.

The primary forms of vancomycin are injectable solutions and powder for injection. Injectable solutions are pre-mixed liquids for intravenous use, ensuring swift and effective treatment of severe infections by directly delivering the drug into the bloodstream. The routes of administration include intravenous and oral methods, targeting applications such as sepsis, lung and skin infections, colitis, and for preventative measures against infections.

The vancomycin market research report is one of a series of new reports from The Business Research Company that provides vancomycin market statistics, including vancomycin industry global market size, regional shares, competitors with a vancomycin market share, detailed vancomycin market segments, market trends, and opportunities, and any further data you may need to thrive in the vancomycin industry. This vancomycin research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vancomycin market size has grown rapidly in recent years. It will grow from $0.82 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to rising detection and prevention of infectious diseases, rise in government-funded programs for disease surveillance, increasing global travel and trade, growing use in hospital settings, and increased healthcare spending.

The vancomycin market size is expected to see rapid growth in the next few years. It will grow to $1.4 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to the increasing emergence of novel pathogens, increasing demand for rapid and on-site testing solutions, growing emphasis on early detection systems, rising demand for vancomycin, and increased R&D activities. Major trends in the forecast period include miniaturization and portability of diagnostic devices, adoption of multiplex assays capable of detecting multiple pathogens simultaneously, integration of digital health solutions, adoption of next-generation sequencing (NGS) technologies in infectious disease diagnostics, advancements in biosensor technologies and integration of AI and machine learning algorithms into diagnostic platforms.

The vancomycin market is poised for growth due to the increasing prevalence of infectious diseases caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. Factors contributing to this rise include antimicrobial resistance, climate change, and population growth. Vancomycin plays a critical role in treating severe gram-positive bacterial infections, particularly resistant strains, following clinical guidelines and antimicrobial stewardship for optimal patient outcomes. For example, the global HIV/AIDS population exceeded 39 million in 2023, showing a 3.17% increase from 2020, as reported by UNAIDS. Additionally, tuberculosis (TB) cases in the US rose by 5.9% from 2021 to 2022, according to the Centers for Disease Control and Prevention.

Key players in the vancomycin market are actively developing innovative products such as anti-infective and anti-hypotensive medications to maintain their market position. Anti-infective medications target infections caused by various microorganisms, while anti-hypotensive medications are used to raise blood pressure in individuals with hypotension. For instance, Baxter International Inc. launched five injectable products in the US in April 2024, addressing anesthesia, pain management, and specialized therapies needs, demonstrating a commitment to improving patient outcomes.

In January 2023, Fairlong Capital LLC acquired DoseMeRx from Tabula Rasa HealthCare Group Inc., expanding its presence in healthcare technology with DoseMeRx's clinical decision support software for personalized dosing. DoseMeRx assists pharmacists and physicians in accurately tailoring doses of high-risk parenteral medications to individual patient needs.

Major companies operating in the vancomycin market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., bioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics Pvt. Ltd., DiaSorin SpA, Myriad Genetics Inc., Seegene Inc., ANI Pharmaceuticals Inc., Alvogen Inc., Biodesix Inc., Helix OpCo LLC, Inovio Pharmaceuticals Inc.

North America was the largest region in the vancomycin market in 2024. The regions covered in the vancomycin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vancomycin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vancomycin market consists of sales of intravenous (IV) formulations, compounded products, diagnostic kits and monitoring devices, therapeutic drug monitoring (TDM) kits, and diagnostic devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vancomycin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vancomycin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vancomycin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vancomycin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Injectable Solution; Powder For Injection
• 2) By Route Of Administration: Intravenous; Oral
• 3) By Application: Sepsis; Lung Infection; Skin Soft Tissue Infection; Colitis And Intestinal Inflammation; To Prevent Infection
• Subsegments:
• 1) By Injectable Solution: Pre-Mixed Injectable Solution; Ready-To-Use Injectable Solution; Concentrated Injectable Solution
• 2) By Powder For Injection: Vancomycin Powder For Intravenous Use; Vancomycin Powder For Reconstitution
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; Becton Dickinson And Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vancomycin Market Characteristics

3. Vancomycin Market Trends And Strategies

4. Vancomycin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Vancomycin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vancomycin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vancomycin Market Growth Rate Analysis
• 5.4. Global Vancomycin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vancomycin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vancomycin Total Addressable Market (TAM)

6. Vancomycin Market Segmentation

• 6.1. Global Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Solution
• Powder For Injection
• 6.2. Global Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous
• Oral
• 6.3. Global Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sepsis
• Lung Infection
• Skin Soft Tissue Infection
• Colitis And Intestinal Inflammation
• To Prevent Infection
• 6.4. Global Vancomycin Market, Sub-Segmentation Of Injectable Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Mixed Injectable Solution
• Ready-To-Use Injectable Solution
• Concentrated Injectable Solution
• 6.5. Global Vancomycin Market, Sub-Segmentation Of Powder For Injection, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vancomycin Powder For Intravenous Use
• Vancomycin Powder For Reconstitution

7. Vancomycin Market Regional And Country Analysis

• 7.1. Global Vancomycin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vancomycin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vancomycin Market

• 8.1. Asia-Pacific Vancomycin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vancomycin Market

• 9.1. China Vancomycin Market Overview
• 9.2. China Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vancomycin Market

• 10.1. India Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vancomycin Market

• 11.1. Japan Vancomycin Market Overview
• 11.2. Japan Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vancomycin Market

• 12.1. Australia Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vancomycin Market

• 13.1. Indonesia Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vancomycin Market

• 14.1. South Korea Vancomycin Market Overview
• 14.2. South Korea Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vancomycin Market

• 15.1. Western Europe Vancomycin Market Overview
• 15.2. Western Europe Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vancomycin Market

• 16.1. UK Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vancomycin Market

• 17.1. Germany Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vancomycin Market

• 18.1. France Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vancomycin Market

• 19.1. Italy Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vancomycin Market

• 20.1. Spain Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vancomycin Market

• 21.1. Eastern Europe Vancomycin Market Overview
• 21.2. Eastern Europe Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vancomycin Market

• 22.1. Russia Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vancomycin Market

• 23.1. North America Vancomycin Market Overview
• 23.2. North America Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vancomycin Market

• 24.1. USA Vancomycin Market Overview
• 24.2. USA Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vancomycin Market

• 25.1. Canada Vancomycin Market Overview
• 25.2. Canada Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vancomycin Market

• 26.1. South America Vancomycin Market Overview
• 26.2. South America Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vancomycin Market

• 27.1. Brazil Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vancomycin Market

• 28.1. Middle East Vancomycin Market Overview
• 28.2. Middle East Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vancomycin Market

• 29.1. Africa Vancomycin Market Overview
• 29.2. Africa Vancomycin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vancomycin Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vancomycin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vancomycin Market Competitive Landscape And Company Profiles

• 30.1. Vancomycin Market Competitive Landscape
• 30.2. Vancomycin Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Becton Dickinson And Company Overview, Products and Services, Strategy and Financial Analysis

31. Vancomycin Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Hologic Inc.
• 31.3. bioMerieux SA
• 31.4. Sysmex Corporation
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. QIAGEN N.V.
• 31.7. Ortho Clinical Diagnostics Pvt. Ltd.
• 31.8. DiaSorin SpA
• 31.9. Myriad Genetics Inc.
• 31.10. Seegene Inc.
• 31.11. ANI Pharmaceuticals Inc.
• 31.12. Alvogen Inc.
• 31.13. Biodesix Inc.
• 31.14. Helix OpCo LLC
• 31.15. Inovio Pharmaceuticals Inc.

32. Global Vancomycin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vancomycin Market

34. Recent Developments In The Vancomycin Market

35. Vancomycin Market High Potential Countries, Segments and Strategies

• 35.1 Vancomycin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vancomycin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vancomycin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer